Main clinical characteristics of 891 patients with WHO-defined essential thrombocythemia
| Characteristics . | . |
|---|---|
| Median age, y (range) | 56 (13-91) |
| Male/female | 370/521 |
| Median leukocyte count, ×109/L (range) | 8.6 (5.3-14.2) |
| Median hemoglobin, g/dL (range) | 14.1 (11.9-16.1) |
| Median platelet count, ×109/L (range) | 774 (500-1464) |
| Median LDH, mU/mL (range) | 298 (150-582) |
| Splenomegaly (proportion) | 146 (16%) |
| Median circulating CD34+, mcL (range) | 2 (0-15.2) |
| Grade 1 fibrosis (proportion) | 24 (3%) |
| Characteristics . | . |
|---|---|
| Median age, y (range) | 56 (13-91) |
| Male/female | 370/521 |
| Median leukocyte count, ×109/L (range) | 8.6 (5.3-14.2) |
| Median hemoglobin, g/dL (range) | 14.1 (11.9-16.1) |
| Median platelet count, ×109/L (range) | 774 (500-1464) |
| Median LDH, mU/mL (range) | 298 (150-582) |
| Splenomegaly (proportion) | 146 (16%) |
| Median circulating CD34+, mcL (range) | 2 (0-15.2) |
| Grade 1 fibrosis (proportion) | 24 (3%) |
LDH indicates lactate dehydrogenase.